TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE B-

NCT06007846: A Prospective Study of Memantine in Patients With Cirrhosis and Liver Cancer

Sponsor: Inova Health Care Services · Phase: PHASE2/PHASE3 · Area: ONCOLOGY · Target Enrollment: 20 pts

Competing Trials Overlap

4 Active Trials

Excess Burn Exposure

$1,240,008

Rescue Site Savings

+$845,460

Unlock Full NCT06007846 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT06007846 Rescue Dossier →